Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Publicaciones realizadas por los miembros de la Fundación.
Carreño V, Hernández-Guío C, Bartolomé J, Quiroga JA. Rev Esp Enf Digest 1993; 83: 169-175.
Significance of low HDV replication levels during the natural history of HDV infection
Madejón A, Castillo I, Cotonat T,Carreño V. J Hepatol 1993; 17: s157-s160.
Virus C de la hepatitis: vacunación y tratamiento problemáticos
Carreño V.Rev Clin Esp 1993; 192: 155-156.
Other approaches to the treatment of chronic viral hepatitis
Carreño V, Marriott E, Quiroga JA. J Hepatol 1993; 17: s127-s129.
Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus
Caramelo C, Ortiz A, Aguilera B, Porres JC, Navas S, Marriott E, Alberola ML, Alamo C, Galera A, Garron MP, González-Parra E, Fernández de Gabriel MV, Oliva H,Carreño V.Am J Kidney Dis 1993; 22: 822-828.
Liver transplantation in chronic viral B and C hepatitis.
Moreno-González E, Loinaz C, García I, Lumbreras C, Gómez R, Moraleda G, Pinto IG, Colina F, Jiménez C,Carreño V, Bercedo J, Ibañez J, Alberti N, Maffettone V. J Hepatol 1993; 17: s116-122.
Liver biopsy and the etiologic diagnosis of chronic hepatitis.
Moreno A, Martinez CJ,Carreño V. J Hepatol 1993; 17: s112-s115.
Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B
Martín J, Bosch O, Moraleda G, Bartolomé J, Quiroga JA,Carreño V. Hepatology 1993; 18: 775-780.
Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells.
Bartolomé J, Castillo I, Quiroga JA, Navas S,Carreño V. J Hepatol 1993; 17: s90-s93.
Treatment of chronic hepatitis B with recombinant interferon alpha versus recombinant interferon alpha plus levamisole.
Bosch O, Moraleda G, Castillo I,Carreño V. J Hepatol 1993; 19: 437-441.
ltimos avances en hepatología.
Carreño V, Quiroga JA.Hepatol Clin 1993; 1: 224-244
Persistence of hepatitis B virus DNA after eduction of viral replication in serum and liver
Molina J, Bartolomé J, Moraleda G, Ruiz-Moreno M, Rúa MJ, Moreno A,Carreño V. J Med Virol 1992; 38: 11-15.
An escalating dose regime of recombinant interpheron-alpha 2A in the treatment of chronic hepatitis C.
Bosch O, Tapia L, Quiroga JA,Carreño V. J Hepatol 1993; 17: 146-149.
Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B
Ruiz-Moreno M, Rúa MJ, Moraleda G, Guardia L, Moreno A,Carreño V. Pediatrics 1992; 90: 254-258.
Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
Quiroga JA, Bosch O, Gonzalez R, Marriott E, Castillo I, Bartolomé J,Carreño V. Gastroenterology 1992; 103: 1285-1289.
Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy.
Carreño V, Castillo I, Molina J, Porres JC, Bartolomé J. J Hepatol 1992; 15: 102-106.
Increase in triglicerides during alpha interferon treatment of chronic viral hepatitis.
Ruíz-Moreno M,Carreño V, Rúa MJ, Cotonat T, Serrano B, Santos M, Marriott E. J Hepatol 1992; 16: 384.
Re-Treatment of chronic hepatitis C with alpha-interferon.
Marriott E, Quiroga JA,Carreño V. J Infect Dis 1992; 166: 1200-1.
Positive ELISA-2 is pathologically relevant in ELISA-1-negative patients on hemodialysis.
Caramelo C,Carreño V, González-Parra E, Quiroga JA, Garrón MP, Marriott E, Ortíz A, Galera A, López MD, Porres JC. Nephron 1992; 61: 474.
Comparison of several PCR procedures for detection of HCV RNA using different regions of the HCV genome
Castillo I, Bartolomé J, Quiroga JA,Carreño V. J Virol Methods 1992; 38: 71-80.